SCHEMBL30427455

SCHEMBL30427455

COc1ccc(S(=O)(=O)n2ccc(OC)c2-c2ccc(F)cc2F)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PABPC1 P11940 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ SCN9A Q15858 3/20 0.40
▸ ALPL P05186 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ HTR6 P50406 4/20 0.38
▸ OXTR P30559 1/20 0.37
▸ AVPR1A P37288 1/20 0.37
▸ KCNH2 Q12809 3/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ TDO2 P48775 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30427210 0.88 MEN1 (0.39) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL30456445 0.87 AVPR2 (0.41) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL29719608 0.81 MEN1 (0.49) MEN1KMT2APOLBHTR6HTR2A
SCHEMBL28996379 0.80 ERN1 (0.41) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL30287363 0.80 ERN1 (0.41) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL28997127 0.79 MEN1 (0.36) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL30287349 0.79 MEN1 (0.36) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL30287336 0.78 KMT2A (0.38) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL28996384 0.78 KMT2A (0.38) MEN1KMT2APABPC1PTGS1PTGS2
SCHEMBL26650833 0.78 MEN1 (0.37) MEN1KMT2APABPC1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023090942-A1 PYRROLE DERIVATIVE OR PHARMACEUTICALLY OR SITOLOGICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF GASTROINTESTINAL DISORDERS COMPRISING SAME AS ACTIVE INGREDIENT 하나제약 주식회사 2023-05-25 — — WO disclosed
Send feedback